Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bristol-Myers, Celgene CEOs trot out detailed case for $74B megadeal

fiercepharmaJanuary 09, 2019

Tag: megadeal , detailed case , Bristol-Myers , megadeal

PharmaSources Customer Service